Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.

Nasal high flow does not improve exercise tolerance in COPD patients after exacerbation

Stephen Padilla
21 Oct 2019

Nasal high flow (NHF) during exercise has failed to boost endurance time in patients with chronic obstructive pulmonary disease (COPD) who are recovering from acute exacerbation, as shown in a recent study.

In this monocentric, randomized, controlled crossover study, the investigators hypothesized that NHF would improve exercise tolerance in COPD patients following exacerbation by reducing respiratory work and improving gas exchange. To test this hypothesis, patients with severe to very severe COPD performed two high-intensity constant work-rate exercise tests (CWRET) with and without NHF for 2 consecutive days.

The mean difference in endurance time between both conditions was the main outcome. Secondary outcomes included vastus lateralis oxygenation (StO2), dyspnoea, leg discomfort, maximal inspiratory pressure (MIP), transcutaneous CO2 pressure (PtcCO2), respiratory rate (RR), heart rate (HR) and pulsed O2 saturation (SpO2), as well as the patients' opinions of the device.

Nineteen patients (mean age, 62.1±9.1 years) were included in the analysis, with mean forced expiratory volume in 1 s of 28.7±10.8 percent.

There were no significant differences seen between the two test conditions in terms of endurance time during the CWRET (–66.58 s, 95 percent CI, –155.9 to 22.7, p=0.12). However, NHF led to a reduction in StO2 (–2.1 percent, –4.3 to 0.0), PtCO2 (–1.3 mm Hg, –2.5 to –0.2) and HR (–2.7 bpm, –5.0 to –0.5) at the end of the exercise (p≤0.05). No significant differences were found for any of the other secondary outcomes. [Respirology 2019;24:1088-1094]

In addition, half of the patients found the device to be moderately or very uncomfortable to use.

A single-centre randomized controlled cross-over trial in 24 hospital inpatients with acute exacerbations of COPD receiving oxygen via standard nasal prongs (SNPs) reported a small reduction in PtCO2 with short-term use of NHF compared with SNP. However, the researchers were uncertain whether this finding was clinically significant. [Respirology 2017;22:1149-1155]

This was supported by another single-blind randomized controlled crossover trial which involved 48 COPD patients. Results showed that NHF led to a small flow-dependent reduction in in PtCO2 and respiratory rate in patients with stable COPD. [Respirology 2018;23:378-384]

On the other hand, a recent single-blind randomized controlled two-way crossover single-centre trial conducted in New Zealand and included 24 patients with stable hypercapnic COPD found that noninvasive ventilation reduced the PtCO2 more than NHF. However, participants evaluated NHF as significantly better for ease of application, comfort and fit. [Respirology 2019;24:1081-1087]

NHF is a device that delivers heated and humidified oxygen up to 60 L/min. Its potential benefits are as follows: the improvement of lung mucociliary clearance, the washout of upper airway dead space, the generation of a low level of positive airway pressure (PEEP effect), the decrease in inspiratory resistance and the increase in expiratory resistance. [COPD 2017;14:346-350]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.